Susquehanna Portfolio Strategies’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-207,527
Closed -$33.9M 967
2026
Q1
$33.9M Hold
207,527
0.5% 47
2025
Q4
$36.1M Hold
207,527
0.56% 35
2025
Q3
$29.9M Hold
207,527
0.47% 46
2025
Q2
$20.9M Buy
+207,527
New +$15.9M 0.46% 52
2024
Q4
Sell
-11,319
Closed -$826K 167
2024
Q3
$826K Hold
11,319
0.06% 213
2024
Q2
$758K Sell
11,319
-10,100
-47% -$392K 0.03% 322
2024
Q1
$581K Sell
21,419
-143,077
-87% -$4M 0.01% 564
2023
Q4
$5.1M Buy
+164,496
New +$4.27M 0.09% 280

Other funds holding INSM

Susquehanna Portfolio Strategies's INSM Position: Q2 2026 in Review

Susquehanna Portfolio Strategies sold out of Insmed (INSM) in Q2 2026, closing a stake of 207,527 shares — an estimated $33.9M sold.

Susquehanna Portfolio Strategies first reported a position in INSM in Q4 2023 and held it in 8 quarters. The position peaked at $36.1M in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Susquehanna Portfolio Strategies reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 207,527 Insmed shares in Q2 2026, an estimated $33.9M.
  • Susquehanna Portfolio Strategies first reported a position in Insmed in Q4 2023 and held it in 8 quarters.
  • Susquehanna Portfolio Strategies's Insmed position peaked at $36.1M in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.